文献速递冠心病心力衰竭与心肌病

心肌梗死后一级预防ICD的死亡获益随时间演变:PROFID研究

Mortality reduction with implanted defibrillator for primary prevention of sudden death after Myocardial Infarction: temporal trends in the PROFID study.
PubMed 文献 · Eur Heart J · 2026-08-28

PROFID研究汇总了32,214例心肌梗死后LVEF≤35%的患者个体数据,比较植入与未植入一级预防ICD患者的全因死亡。按入选年份分为1995-2004、2005-2014和2015-2020三个时期,经倾向评分重叠加权后发现ICD相关的死亡获益随时间推移逐渐减弱。

要点

  • 心肌梗死后LVEF≤35%患者中,一级预防ICD的死亡获益随时间推移逐渐减弱。
  • 2015-2020年期间,ICD与非ICD患者的全因死亡风险无显著差异。
  • 当代心梗与心衰管理进步后,需重新评估一级预防ICD的常规植入决策。

核心结论

  • 在心肌梗死后LVEF降低的大型队列中,一级预防ICD植入相关的死亡获益随时间推移逐渐减弱。
  • 2015-2020年期间,ICD与非ICD患者的加权累积死亡曲线几乎无分离。

研究设计与样本

  • PROFID汇总队列纳入32,214例心肌梗死后LVEF≤35%的患者,其中7,477例植入一级预防ICD,24,737例未植入ICD。
  • 采用多变量logistic回归估计倾向评分,并用重叠加权平衡治疗组间差异。
  • 按入选年份预设三个时期:1995-2004、2005-2014和2015-2020。
  • 采用加权Cox比例风险模型评估ICD植入与死亡降低关联的时间变化。

主要发现

  • 平均随访43.7个月,共发生12,097例死亡。
  • ICD植入与死亡的关联在不同时期有显著变化,交互作用P<0.001。
  • 1995-2004年ICD对比非ICD患者的死亡风险比为0.54(95%CI 0.47-0.62;P<0.001)。
  • 2005-2014年死亡风险比为0.67(95%CI 0.62-0.72;P<0.001)。
  • 2015-2020年死亡风险比为0.89(95%CI 0.73-1.07;P=0.221)。

关键数值与推荐

  • 患者入选标准为心肌梗死后LVEF≤35%。
  • 主要终点为全因死亡。
  • 倾向评分纳入的变量包括年龄、性别、LVEF、肾功能和糖尿病。

临床怎么用

  • 对于符合传统一级预防ICD指征的心梗后LVEF降低患者,应结合当代药物治疗背景个体化评估植入获益。
  • 2015年之后入选的患者中,ICD相关死亡获益不再显著,临床决策需更审慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIM: Randomized trials conducted in the early 2000s established the survival benefit of primary prevention implantable cardioverter-defibrillator (ICD) therapy in patients with reduced left ventricular ejection fraction (LVEF) after myocardial infarction. However, management of myocardial infarction and heart failure has substantially evolved since that time. We investigated whether the estimated association between primary prevention ICD implantation in post-myocardial infarction patients with reduced LVEF and mortality reduction has changed over time. METHODS: We analyzed individual participant data from 32,214 patients with LVEF ≤35% after myocardial infarction included in the PROFID pooled cohort, comprising 7,477 patients carrying a primary prevention ICD (ICD patients) and 24,737 patients without an ICD (non-ICD patients). The primary endpoint was all-cause mortality. Propensity scores were estimated using multivariable logistic regression including age, sex, LVEF, renal function, and diabetes, and overlap weighting was applied to balance treatment groups. Time period-specific analyses were performed across three prespecified time periods defined by inclusion year: 1995-2004, 2005-2014, and 2015-2020. Weighted cumulative mortality curves were generated for each time period. Temporal changes in the estimated association between ICD implantation and mortality reduction were assessed using a weighted Cox proportional hazards model. RESULTS: A total of 12,097 deaths occurred during a mean follow-up of 43.7 months. The estimated association between ICD implantation and mortality changed significantly across time (P for interaction <0.001). In weighted time period-specific analyses, the estimated mortality reduction associated with ICD implantation progressively decreased over more recent periods. The hazard ratio for ICD versus non-ICD patients was 0.54 (95% CI 0.47-0.62; P<0.001) in 1995-2004, 0.67 (95% CI 0.62-0.72; P<0.001) in 2005-2014, and 0.89 (95% CI 0.73-1.07; P=0.221) in 2015-2020, with negligible separation of the weighted cumulative mortality curves in the most recent time period. CONCLUSIONS: In this analysis including a large cohort of post-myocardial infarction patients with reduced LVEF, the estimated mortality reduction associated with primary prevention ICD implantation progressively decreased over time.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Sepehri Shamloo, Chiba, Tijssen, et al. Mortality reduction with implanted defibrillator for primary prevention of sudden death after Myocardial Infarction: temporal trends in the PROFID study. Eur Heart J. 2026. PMID: 42663237. doi:10.1093/eurheartj/ehag706

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。